When the original melanoma cells with wild-type PTEN were changed to inactivated PTEN status, they became resistant to BRAF inhibition; they had similarly upregulated PERK, confirming that PERK upregulation in resistant melanoma is dependent on PTEN. Here, BRAF is linked to melanoma.